The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors

This publication has 44 references indexed in Scilit:

• Chondroitin sulfate-tocopherol succinate modified exosomes for targeted drug delivery to CD44-positive cancer cells
  International Journal of Biological Macromolecules, 2024
• Targeted delivery of liposomal Ribociclib to SLC7A5 transporters in breast cancer cells
  Investigational New Drugs, 2023
• Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
  International Journal of Cancer, 2018
• The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair
  Cancer Letters, 2016
• Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate–anthocyanin nanocomplex for efficient tumor therapy
  Journal of Controlled Release, 2016
• P-selectin enhances growth and metastasis of mouse mammary tumors by promoting regulatory T cell infiltration into the tumors
  Life Sciences, 2015
• CD44, a therapeutic target for metastasising tumours
  European Journal of Cancer, 2010
• What is triple-negative breast cancer?
  European Journal of Cancer, 2008
• Chondroitin sulfate glycosaminoglycans as major P‐selectin ligands on metastatic breast cancer cell lines
  International Journal of Cancer, 2006
• Preparation and physicochemical properties of various soybean lecithin liposomes using supercritical reverse phase evaporation method
  Colloids and Surfaces B: Biointerfaces, 2003